Xiaobing Liang

469 total citations
18 papers, 352 citations indexed

About

Xiaobing Liang is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaobing Liang has authored 18 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaobing Liang's work include DNA Repair Mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Mechanisms and Therapy (2 papers). Xiaobing Liang is often cited by papers focused on DNA Repair Mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Mechanisms and Therapy (2 papers). Xiaobing Liang collaborates with scholars based in China, United States and Kenya. Xiaobing Liang's co-authors include Ramin Altaha, Eddie Reed, Xuelan Wang, Eddie Reed, Jing Yu, Thomas F. Hogan, Qi He, H. James Williams, Antonio Tito Fojo and John J. Pink and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Xiaobing Liang

17 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Liang China 9 176 129 55 50 47 18 352
Hayato Urushima Japan 10 129 0.7× 108 0.8× 52 0.9× 30 0.6× 37 0.8× 19 389
Konrad Zaręba Poland 11 161 0.9× 131 1.0× 66 1.2× 47 0.9× 63 1.3× 46 436
Antonietta Fabbrocini Italy 9 123 0.7× 157 1.2× 44 0.8× 35 0.7× 42 0.9× 13 370
Krista LaPerle United States 7 191 1.1× 124 1.0× 41 0.7× 31 0.6× 41 0.9× 8 499
Wenxiang Shen China 9 240 1.4× 106 0.8× 90 1.6× 34 0.7× 57 1.2× 17 396
Yajie Xiao China 11 118 0.7× 97 0.8× 50 0.9× 34 0.7× 39 0.8× 41 345
Zixiang Zhang China 13 151 0.9× 179 1.4× 55 1.0× 24 0.5× 86 1.8× 25 424
Zhenzhong Feng China 11 152 0.9× 130 1.0× 85 1.5× 60 1.2× 59 1.3× 29 371
Mei‐Due Yang Taiwan 12 144 0.8× 58 0.4× 39 0.7× 32 0.6× 102 2.2× 32 353

Countries citing papers authored by Xiaobing Liang

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Liang more than expected).

Fields of papers citing papers by Xiaobing Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Liang. The network helps show where Xiaobing Liang may publish in the future.

Co-authorship network of co-authors of Xiaobing Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Liang. A scholar is included among the top collaborators of Xiaobing Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Liang. Xiaobing Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Liang, Xiaobing, et al.. (2025). Research Progress on Continuous-Flow Nitrification Technology and Equipment. SHILAP Revista de lepidopterología. 7(2). e77–e90.
3.
Sasikumar, K., Nicholas Blazanin, Yuanxin Xi, et al.. (2024). Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancer. Cell chemical biology. 31(12). 2069–2084.e9. 8 indexed citations
4.
Yang, Yue, et al.. (2023). A multi-energy microgrid configuration method in remote rural areas considering the condition value at risk. Frontiers in Energy Research. 11. 4 indexed citations
5.
Zhao, Mingyi, Xiaoying Liu, Hao Yan, et al.. (2023). A bibliometric analysis of studies on gut microbiota in attention-deficit and hyperactivity disorder from 2012 to 2021. Frontiers in Microbiology. 14. 1055804–1055804. 6 indexed citations
6.
Chen, Yang, Shaoguang Li, Xiaoqi Wu, et al.. (2022). Design and biological features of platinum (II) complexes with 3-hydroxy-3-(Trifluoromethyl)cyclobutane-1,1-Dicarboxylate as a leaving ligand. European Journal of Medicinal Chemistry. 242. 114673–114673. 8 indexed citations
7.
Liang, Xiaobing, Wanbing He, Hua Zhang, et al.. (2021). Inflammatory Cells Accelerated Carotid Artery Calcification via MMP9: Evidences From Single-Cell Analysis. Frontiers in Cardiovascular Medicine. 8. 766613–766613. 7 indexed citations
8.
9.
Liang, Xiaobing, et al.. (2019). Ellagic Acid Ameliorates Renal Ischemic-Reperfusion Injury Through NOX4/JAK/STAT Signaling Pathway. Inflammation. 43(1). 298–309. 38 indexed citations
10.
Hogan, Thomas F., Shunchang Jiao, Mohamad Salkini, et al.. (2019). Adverse Effects Profile of Dicycloplatin (DCP) Offers Chemotherapeutic Advantage Over Cisplatin and Carboplatin. Anticancer Research. 39(8). 4455–4462. 7 indexed citations
11.
Liang, Xiaobing, et al.. (2018). Ellagic acid promotes A549 cell apoptosis via regulating the phosphoinositide 3‑kinase/protein kinase B pathway. Experimental and Therapeutic Medicine. 16(1). 347–352. 29 indexed citations
12.
Yu, Jing, Pingfu Fu, John J. Pink, et al.. (2010). HPV Infection and EGFR Activation/Alteration in HIV-Infected East African Patients with Conjunctival Carcinoma. PLoS ONE. 5(5). e10477–e10477. 25 indexed citations
13.
Liang, Xiaobing, Yi Guo, William D. Figg, et al.. (2010). The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 Inhibitor. PubMed. 2011. 1–8. 13 indexed citations
14.
Hogan, Thomas F., Jing Yu, H. James Williams, et al.. (2009). Oncocytic, focally anaplastic, thyroid cancer responding to erlotinib. Journal of Oncology Pharmacy Practice. 15(2). 111–117. 20 indexed citations
15.
Liang, Xiaobing, et al.. (2006). Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells. International Journal of Molecular Medicine. 17(5). 703–8. 27 indexed citations
16.
Altaha, Ramin, et al.. (2004). Excision repair cross complementing-group 1: Gene expression and platinum resistance (Review) parameters in human breast cancer. International Journal of Molecular Medicine. 14(6). 959–70. 146 indexed citations
17.
Liang, Xiaobing, et al.. (2004). Confirmation of 42-bp deletion within the ERCC1 5' UTR.. International Journal of Oncology. 25(4). 1105–1116. 2 indexed citations
18.
Liang, Xiaobing, et al.. (2002). An improved passive input current waveshaping method for single-phase diode rectifier. 2. 695–699. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hayato Urushima Breakdown of academic impact, for papers by Konrad Zaręba Breakdown of academic impact, for papers by Antonietta Fabbrocini Breakdown of academic impact, for papers by Krista LaPerle Breakdown of academic impact, for papers by Wenxiang Shen Breakdown of academic impact, for papers by Yajie Xiao Breakdown of academic impact, for papers by Zixiang Zhang Breakdown of academic impact, for papers by Zhenzhong Feng Breakdown of academic impact, for papers by Mei‐Due Yang
Rankless by CCL
2026